<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(4)</volume><submitter>Farr RJ</submitter><pubmed_abstract>Host biomarkers are increasingly being considered as tools for improved COVID-19 detection and prognosis. We recently profiled circulating host-encoded microRNA (miRNAs) during SARS-CoV-2 infection, revealing a signature that classified COVID-19 cases with 99.9% accuracy. Here we sought to develop a signature suited for clinical application by analyzing specimens collected using minimally invasive procedures. Eight miRNAs displayed altered expression in anterior nasal tissues from COVID-19 patients, with miR-142-3p, a negative regulator of interleukin-6 (IL-6) production, the most strongly upregulated. Supervised machine learning analysis revealed that a three-miRNA signature (miR-30c-2-3p, miR-628-3p and miR-93-5p) independently classifies COVID-19 cases with 100% accuracy. This study further defines the host miRNA response to SARS-CoV-2 infection and identifies candidate biomarkers for improved COVID-19 detection.</pubmed_abstract><journal>PloS one</journal><pagination>e0265670</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8982876</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract.</pubmed_title><pmcid>PMC8982876</pmcid><pubmed_authors>Stewart CR</pubmed_authors><pubmed_authors>Cowled C</pubmed_authors><pubmed_authors>Farr RJ</pubmed_authors><pubmed_authors>Stenos J</pubmed_authors><pubmed_authors>Foo CH</pubmed_authors><pubmed_authors>Rootes CL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract.</name><description>Host biomarkers are increasingly being considered as tools for improved COVID-19 detection and prognosis. We recently profiled circulating host-encoded microRNA (miRNAs) during SARS-CoV-2 infection, revealing a signature that classified COVID-19 cases with 99.9% accuracy. Here we sought to develop a signature suited for clinical application by analyzing specimens collected using minimally invasive procedures. Eight miRNAs displayed altered expression in anterior nasal tissues from COVID-19 patients, with miR-142-3p, a negative regulator of interleukin-6 (IL-6) production, the most strongly upregulated. Supervised machine learning analysis revealed that a three-miRNA signature (miR-30c-2-3p, miR-628-3p and miR-93-5p) independently classifies COVID-19 cases with 100% accuracy. This study further defines the host miRNA response to SARS-CoV-2 infection and identifies candidate biomarkers for improved COVID-19 detection.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-04-08T17:46:39.357Z</modification><creation>2025-02-19T01:55:02.598Z</creation></dates><accession>S-EPMC8982876</accession><cross_references><pubmed>35381016</pubmed><doi>10.1371/journal.pone.0265670</doi></cross_references></HashMap>